NHS will offer pembrolizumab cervical cancer drug in England
The change brings England in line with Scotland and should help women with advanced disease live longer. …
NHS England’s director of specialised commissioning and interim commercial medicines director, John Stewart, said: “After nearly 15 years without a new treatment for this type of advanced cervical cancer, this first immunotherapy marks a significant step forward that will provide hundreds of people with precious time with their loved ones.
About The Author
